← FDA Drug Approvals (Drugs@FDA)

ZYNLONTA

BLA · Biologics License Application · Sponsor: ADC Therapeutics SA · Approved 2021-04-23

Drug application

FDA Application #

BLA761196

Application type

Biologics License Application

Brand name

ZYNLONTA

Generic name

LONCASTUXIMAB TESIRINE

Active ingredients

LONCASTUXIMAB TESIRINE-LPYL

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

ADC Therapeutics SA

Manufacturer

ADC Therapeutics America, Inc.

First approval

2021-04-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown